Torthaí cuardaigh - Quentin M. Anstee

Beachtaigh na torthaí
  1. 1
    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research de réir Quentin M. Anstee, Robert Goldin

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 de réir Christopher P. Day, Quentin M. Anstee

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility

    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility de réir Quentin M. Anstee, Christopher P. Day

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment de réir Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis de réir Mazen Noureddin, Quentin M. Anstee, Rohit Loomba

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease de réir Marie Boyle, Steven Masson, Quentin M. Anstee

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Impact of non-invasive biomarkers on hepatology practice: Past, present and future

    Impact of non-invasive biomarkers on hepatology practice: Past, present and future de réir Quentin M. Anstee, Laurent Castéra, Rohit Loomba

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease de réir Timothy Hardy, Quentin M. Anstee, Christopher P. Day

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Non-alcoholic fatty liver disease: a practical approach to treatment

    Non-alcoholic fatty liver disease: a practical approach to treatment de réir Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging de réir Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    NAFLD-Associated HCC: Progress and Opportunities

    NAFLD-Associated HCC: Progress and Opportunities de réir Daniel Geh, Quentin M. Anstee, Helen L. Reeves

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Genetic modifiers of non-alcoholic fatty liver disease progression

    Genetic modifiers of non-alcoholic fatty liver disease progression de réir Quentin M. Anstee, Ann K. Daly, Christopher P. Day

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    How big a problem is non-alcoholic fatty liver disease?

    How big a problem is non-alcoholic fatty liver disease? de réir Quentin M. Anstee, Stuart McPherson, C.P. Day

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases de réir Leon A. Adams, Quentin M. Anstee, Herbert Tilg, Giovanni Targher

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    The Global Burden of Liver Disease

    The Global Burden of Liver Disease de réir Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin M. Anstee, Linda Henry

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Thrombin and factor Xa link the coagulation system with liver fibrosis

    Thrombin and factor Xa link the coagulation system with liver fibrosis de réir Ameet Dhar, Fouzia Sadiq, Quentin M. Anstee, Adam Levene, Robert Goldin, Mark Thursz

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study

    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease... de réir Kate Hallsworth, Stephan U Dombrowski, Stuart McPherson, Quentin M. Anstee, Leah Avery

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease de réir Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis

    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis de réir Helen Jarvis, Hannah O’Keefe, Dawn Craig, Daniel Stow, Barbara Hanratty, Quentin M. Anstee

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice

    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice de réir Leah Avery, Catherine Exley, Stuart McPherson, Michael I. Trenell, Quentin M. Anstee, Kate Hallsworth

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: